News|Articles|August 19, 2011

FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults

FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.

FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults


Related to this article

Stafeeva-stock@adobe.com
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.